JASON BERREMAN: Open Payments
NPI 1225149073 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,237 in 59 payments from 6 companies in 2025. Trend: 2023 $795 · 2024 $1,337 · 2025 $1,237
Food & beverage: $1,046Speaker / faculty: $142Education: $48
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 27 | $549 |
| ABBVIE INC. | 23 | $448 |
| Lilly USA, LLC | 4 | $161 |
| GENZYME CORPORATION | 2 | $46 |
| REVANCE THERAPEUTICS, INC. | 1 | $19 |
| Organon LLC | 2 | $14 |
Products named: TREMFYA, BOTOX, EBGLYSS, RINVOQ, SKYRIZI, DUPIXENT, TALTZ, DAXXIFY.
Industry payments across WA — which companies pay providers there.
